Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Samantha Semenkow is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/24/2025 | BIOA | Buy Now | Bioage Labs | $4.25 | 17.65% | Samantha Semenkow33% | $7 → $5 | Maintains | Neutral | Get Alert |
01/07/2025 | SLRN | Buy Now | Acelyrin | $2.70 | 11.11% | Samantha Semenkow33% | $6 → $3 | Maintains | Neutral | Get Alert |
12/09/2024 | BIOA | Buy Now | Bioage Labs | $4.25 | 64.71% | Samantha Semenkow33% | $45 → $7 | Downgrade | Buy → Neutral | Get Alert |
12/02/2024 | VYGR | Buy Now | Voyager Therapeutics | $3.76 | 219.15% | Samantha Semenkow33% | → $12 | Initiates | → Buy | Get Alert |
10/21/2024 | BIOA | Buy Now | Bioage Labs | $4.25 | 958.82% | Samantha Semenkow33% | → $45 | Initiates | → Buy | Get Alert |
10/17/2024 | ARGX | Buy Now | argenx | $605.52 | 4.87% | Samantha Semenkow33% | $512 → $635 | Maintains | Buy | Get Alert |
08/09/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.63 | 390.83% | Samantha Semenkow33% | $7 → $8 | Maintains | Buy | Get Alert |
08/09/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.75 | 20.39% | Samantha Semenkow33% | $27 → $31 | Maintains | Buy | Get Alert |
08/09/2024 | SANA | Buy Now | Sana Biotechnology | $2.19 | 584.93% | Samantha Semenkow33% | $8 → $15 | Maintains | Buy | Get Alert |
06/03/2024 | SNSE | Buy Now | Sensei Biotherapeutics | $0.45 | 788.89% | Samantha Semenkow33% | → $4 | Reinstates | Buy → Buy | Get Alert |
05/22/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 488.26% | Samantha Semenkow33% | $10 → $14 | Maintains | Buy | Get Alert |
05/16/2024 | PRME | Buy Now | Prime Medicine | $1.96 | 410.2% | Samantha Semenkow33% | → $10 | Upgrade | Neutral → Buy | Get Alert |
05/09/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 1045.04% | Samantha Semenkow33% | $16 → $15 | Maintains | Buy | Get Alert |
04/08/2024 | TSVT | Buy Now | 2seventy bio | $4.96 | 141.94% | Samantha Semenkow33% | $9 → $12 | Maintains | Buy | Get Alert |
04/04/2024 | CABA | Buy Now | Cabaletta Bio | $1.64 | 1728.38% | Samantha Semenkow33% | $26 → $30 | Maintains | Buy | Get Alert |
03/14/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.75 | 4.85% | Samantha Semenkow33% | → $27 | Initiates | → Buy | Get Alert |
02/29/2024 | EDIT | Buy Now | Editas Medicine | $1.31 | 1121.37% | Samantha Semenkow33% | $11 → $16 | Maintains | Buy | Get Alert |
02/13/2024 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 320.19% | Samantha Semenkow33% | $4.5 → $10 | Maintains | Buy | Get Alert |
12/08/2023 | SLRN | Buy Now | Acelyrin | $2.70 | 196.3% | Samantha Semenkow33% | → $8 | Initiates | → Neutral | Get Alert |
12/08/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.63 | 329.47% | Samantha Semenkow33% | → $7 | Initiates | → Buy | Get Alert |
12/08/2023 | MLTX | Buy Now | MoonLake | $39.67 | 81.5% | Samantha Semenkow33% | → $72 | Initiates | → Buy | Get Alert |
12/08/2023 | MORF | Buy Now | Morphic Holding | — | — | Samantha Semenkow33% | → $46 | Initiates | → Buy | Get Alert |
12/08/2023 | PRME | Buy Now | Prime Medicine | $1.96 | 410.2% | Samantha Semenkow33% | → $10 | Initiates | → Neutral | Get Alert |
11/29/2023 | ARGX | Buy Now | argenx | $605.52 | -2.4% | Samantha Semenkow33% | $610 → $591 | Maintains | Buy | Get Alert |
11/17/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 89.08% | Samantha Semenkow33% | → $4.5 | Upgrade | Neutral → Buy | Get Alert |
10/24/2023 | EDIT | Buy Now | Editas Medicine | $1.31 | 739.69% | Samantha Semenkow33% | → $11 | Upgrade | Neutral → Buy | Get Alert |
10/12/2023 | TSVT | Buy Now | 2seventy bio | $4.96 | 162.1% | Samantha Semenkow33% | → $13 | Initiates | → Buy | Get Alert |
09/27/2023 | IMVT | Buy Now | Immunovant | $18.25 | 173.97% | Samantha Semenkow33% | $33 → $50 | Maintains | Buy | Get Alert |
09/05/2023 | SANA | Buy Now | Sana Biotechnology | $2.19 | 265.3% | Samantha Semenkow33% | → $8 | Initiates | → Buy | Get Alert |
09/05/2023 | CABA | Buy Now | Cabaletta Bio | $1.64 | 1240.81% | Samantha Semenkow33% | → $22 | Initiates | → Buy | Get Alert |
08/11/2023 | IMVT | Buy Now | Immunovant | $18.25 | 80.82% | Samantha Semenkow33% | $28 → $33 | Maintains | Buy | Get Alert |
08/09/2023 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 141.07% | Samantha Semenkow33% | $60 → $56 | Maintains | Buy | Get Alert |
07/18/2023 | ARGX | Buy Now | argenx | $605.52 | -2.23% | Samantha Semenkow33% | $450 → $592 | Maintains | Buy | Get Alert |
05/18/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Samantha Semenkow33% | $1.7 → $0.75 | Maintains | Neutral | Get Alert |
05/18/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 89.08% | Samantha Semenkow33% | $7 → $4.5 | Maintains | Neutral | Get Alert |
05/15/2023 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 194.13% | Samantha Semenkow33% | → $7 | Maintains | Neutral | Get Alert |
05/11/2023 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 158.29% | Samantha Semenkow33% | $62 → $60 | Maintains | Buy | Get Alert |
05/03/2023 | NGM | Buy Now | NGM Biopharmaceuticals | — | — | Samantha Semenkow33% | → $6 | Initiates | → Buy | Get Alert |
04/25/2023 | IMVT | Buy Now | Immunovant | $18.25 | 53.42% | Samantha Semenkow33% | → $28 | Initiates | → Buy | Get Alert |
04/25/2023 | ARGX | Buy Now | argenx | $605.52 | -25.68% | Samantha Semenkow33% | → $450 | Initiates | → Buy | Get Alert |
03/16/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Samantha Semenkow33% | $2.7 → $1.7 | Maintains | Neutral | Get Alert |
02/13/2023 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Samantha Semenkow33% | → $2.7 | Initiates | → Neutral | Get Alert |
12/13/2022 | LRMR | Buy Now | Larimar Therapeutics | $2.38 | 68.07% | Samantha Semenkow33% | → $4 | Initiates | → Neutral | Get Alert |
12/13/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.45 | 1233.33% | Samantha Semenkow33% | → $6 | Initiates | → Buy | Get Alert |
12/13/2022 | EDIT | Buy Now | Editas Medicine | $1.31 | 739.69% | Samantha Semenkow33% | → $11 | Initiates | → Neutral | Get Alert |
12/13/2022 | BEAM | Buy Now | Beam Therapeutics | $23.23 | 166.9% | Samantha Semenkow33% | → $62 | Initiates | → Buy | Get Alert |